Teva Presents First Real-World Data from the IMPACT-TD Registry Study at Psych Congress Elevate 2024
Nearly 98% of patients experience quality of life impact as a result of tardive dyskinesia including social, psychological, physical and recreational aspects of daily living Data highlight for...